Package 84612-479-02
Brand: amjevita
Generic: adalimumab-attoPackage Facts
Identity
Package NDC
84612-479-02
Digits Only
8461247902
Product NDC
84612-479
Description
2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE
Marketing
Marketing Status
Brand
amjevita
Generic
adalimumab-atto
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "494c8f53-855d-f506-e063-6294a90ac829", "openfda": {"nui": ["N0000175610", "N0000175451", "M0001357"], "upc": ["0384612399012", "0384612479028"], "unii": ["FYS6T7F842"], "rxcui": ["2663901", "2663904", "2663906", "2663907", "2663908", "2663910", "2663914", "2663915"], "spl_set_id": ["d7862491-2634-4402-b001-dcc1abf8dd58"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Nuvaila Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (84612-479-01) / .4 mL in 1 SYRINGE", "package_ndc": "84612-479-01", "marketing_start_date": "20250101"}, {"sample": false, "description": "2 SYRINGE in 1 CARTON (84612-479-02) / .4 mL in 1 SYRINGE", "package_ndc": "84612-479-02", "marketing_start_date": "20250101"}], "brand_name": "AMJEVITA", "product_id": "84612-479_494c8f53-855d-f506-e063-6294a90ac829", "dosage_form": "INJECTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "84612-479", "generic_name": "adalimumab-atto", "labeler_name": "Nuvaila Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AMJEVITA", "active_ingredients": [{"name": "ADALIMUMAB", "strength": "40 mg/.4mL"}], "application_number": "BLA761024", "marketing_category": "BLA", "marketing_start_date": "20250101", "listing_expiration_date": "20271231"}